Engineers Gate Manager’s Adaptive Biotechnologies ADPT Stock Holding History

Engineers Gate Manager’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$699K	Sell	32,580 -24,960	-43%	-$382K	0.01%	1293
2026 Q1	$799K	Buy	57,540 +35,944	+166%	+$573K	0.01%	1167
2025 Q4	$351K	Sell	21,596 -83,453	-79%	-$1.36M	﹤0.01%	1551
2025 Q3	$1.57M	Buy	+105,049	New	+$1.28M	0.02%	908
2024 Q4	–	Sell	-56,413	Closed	-$289K	–	2186
2024 Q3	$289K	Sell	56,413 -17,014	-23%	-$74.1K	0.01%	1637
2024 Q2	$266K	Buy	73,427 +43,406	+145%	+$138K	0.01%	1527
2024 Q1	$96.4K	Buy	+30,021	New	+$116K	﹤0.01%	1753
2023 Q3	–	Sell	-21,057	Closed	-$141K	–	1750
2023 Q2	$141K	Sell	21,057 -11,042	-34%	-$82.1K	0.01%	1526
2023 Q1	$283K	Buy	32,099 +8,879	+38%	+$78.3K	0.01%	1276
2022 Q4	$177K	Sell	23,220 -8,325	-26%	-$64.8K	0.01%	1408
2022 Q3	$225K	Buy	+31,545	New	+$297K	0.01%	1257

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Engineers Gate Manager's ADPT Position: Q2 2026 in Review

Engineers Gate Manager reduced its Adaptive Biotechnologies (ADPT) stake by 43% in Q2 2026, selling an estimated $382K and leaving 32,580 shares worth $699K. The position accounts for 0.01% of the portfolio, ranked #1293.

Engineers Gate Manager first reported a position in ADPT in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.57M in Q3 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Engineers Gate Manager held 32,580 shares of Adaptive Biotechnologies worth $699K as of Q2 2026.
Engineers Gate Manager sold 24,960 Adaptive Biotechnologies shares in Q2 2026, an estimated $382K.
Adaptive Biotechnologies made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1293 holding.
Engineers Gate Manager first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 11 quarters since.
Engineers Gate Manager's Adaptive Biotechnologies position peaked at $1.57M in Q3 2025.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.